The use of granulocyte colony-stimulating factor to deliver four cycles of ifosfamide and epirubicin every 14 days in women with advanced or metastatic breast cancer.

Por Lind, M. J., Gumbrell, L., Cantwell, B. M., Millward, M. J., Simmonds, D., Proctor, M., Chapman, F., McCann, E., Middleton, I., Calvert, A. H.
Publicado em 1995